The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.

 
Web www.patentalert.com

< Optically active (R)-1-(4-trifluoromethylphenyl)ethylamine

< Follistatin-3

> Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides

> Method for induction of L-selectin shedding
~ 00281